Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Fibroblast activation protein alpha (FAP) ELISA Kit-Sandwich

Cat. No.EK10F909

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Canine FAP ELISA Kit-Sandwich is designed for the quantitative determination of Canine FAP in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Canine FAP.
Target Species Canine
Species Reactivity Canine
Detection Range 62.5-4000 pg/mL
Sensitivity 12.5 pg/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 180 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Fibroblast activation protein alpha is encoded by the FAP gene in dogs. Based on a target selection criteria score, FAP could be considered a target for fluorescence-guided surgery.

Target/Biomarker Canine FAP
Target Synonym fibroblast activation protein alpha; prolyl endopeptidase FAP
Gene ID 608176
UniProt ID A0A8C0NKP1

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Beer, P. et al. Cross-species evaluation of fibroblast activation protein alpha as potential imaging target for soft tissue sarcoma: a comparative immunohistochemical study in humans, dogs, and cats. Frontiers in oncology. 2023, 13: 1210004.
Inquiry Basket